5,6'-dimethyl-2,3'-bipyridine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 5,6'-dimethyl-2,3'-bipyridine
• 英文别名: 5,6'-Dimethyl-[2,3']bipyridinyl；2-methyl-5-(5-methylpyridin-2-yl)pyridine
• 化学式: C₁₂H₁₂N₂
• 分子量: 184.241
• InChiKey: AMXCOIJCCGOHKM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  25.8
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  bis(1,5-cyclooctadiene)diiridium(I) dichloride 、 ammonium hexafluorophosphate 、 5,6'-dimethyl-2,3'-bipyridine 、 4,4'-二叔丁基-2,2'-二吡啶 以 乙二醇乙醚 、 水 为溶剂， 反应 42.0h， 以40%的产率得到C₄₂H₄₆IrN₆⁽¹⁺⁾*F₆P^(1-)
  参考文献：
  名称：

  Fluorine-free blue-green emitters for light-emitting electrochemical cells

  摘要：

  新的无氟铱配合物被合成，旨在提高蓝绿发光LEECs的性能。

  DOI：

  10.1039/c4tc00542b
• 作为产物：
  描述：

  2-溴-5-甲基吡啶 、 2-甲基-5-吡啶硼酸 在 palladium diacetate 、 sodium carbonate 、 三苯基膦 作用下， 以 1,4-二氧六环 、 水 为溶剂， 反应 2.5h， 以83%的产率得到5,6'-dimethyl-2,3'-bipyridine
  参考文献：
  名称：

  Fluorine-free blue-green emitters for light-emitting electrochemical cells

  摘要：

  新的无氟铱配合物被合成，旨在提高蓝绿发光LEECs的性能。

  DOI：

  10.1039/c4tc00542b

文献信息

• [EN] NAPHTHALENE CARBOXAMIDE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS<br/>[FR] COMPOSÉS DE NAPHTHALÈNE CARBOXAMIDE, MODULATEURS ALLOSTÉRIQUES POSITIFS DU RÉCEPTEUR M1
  申请人：MERCK SHARP & DOHME

  公开号：WO2011149801A1

  公开（公告）日：2011-12-01

  The present invention is directed to naphthalene carboxamide compounds of formula (I) which are M1 receptor positive allosteric modulators and that are useful in the treatment of diseases in which the M1 receptor is involved, such as Alzheimers disease, schizophrenia, pain or sleep disorders. The invention is also directed to pharmaceutical compositions comprising the compounds and to the use of the compounds and compositions in the treatment of diseases mediated by the M1 receptor.

  本发明涉及式(I)的萘甲酰胺化合物，它们是M1受体阳性变构调节剂，可用于治疗M1受体参与的疾病，如阿尔茨海默病、精神分裂症、疼痛或睡眠障碍。该发明还涉及包含这些化合物的药物组合物，以及在治疗由M1受体介导的疾病中使用这些化合物和组合物。
• Spiro Compounds As NPY Y5 Receptor Antagonists
  申请人：Biagetti Matteo

  公开号：US20090203705A1

  公开（公告）日：2009-08-13

  The present invention relates to novel compounds of formula (I), or a pharmaceutically acceptable salt thereof, wherein R is an aryl or heteroaryl, which may be substituted by one or more: halogen, C 1 -C 4 alkyl, C1-C4 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 4 haloalkoxy, cyano; Z 1 is H, C 1 -C 4 alkyl or F; Z is CH 2 , CH(C 1 -C 4 alkyl), C(C 1 -C 4 alkyl) 2 or a bond; A is a 6-10 membered aryl or heteroaryl, which may be substituted by one or more: halogen, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 4 haloalkoxy, cyano; or —C(═O)—X; or —O(CH 2 ) 0-1 R 1 ; B is hydrogen or is a 5-6 membered heteroaryl, or a 4-6 membered heterocycle, or phenyl, which may be substituted by one or more: halogen, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 4 haloalkoxy, hydroxyl, cyano; A and B being linked via any atom; R 1 is —(C 1 -C 4 )alkyl(C 1 -C 4 )alkoxy; or C 3 -C 8 cycloalkyl; or R 1 is an aryl or heteroaryl, which may be substituted by one or more: halogen, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 4 haloalkoxy, cyano; or R 1 is a 4-6 membered heterocycle, which may be substituted by one or more: halogen, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 4 haloalkoxy, cyano; X is OR 2 or NR 3 R 4 ; R 2 is C 1 -C 4 alkyl; R 3 is hydrogen or together with R 4 and the nitrogen form a 5-6 saturated membered ring; R 4 is C 3 -C 8 cycloalkyl; processes for their preparation, intermediates used in these processes, pharmaceutical compositions containing them and their use in therapy, as NPY Y5 receptor antagonists and as agents for the treatment and/or prophylaxis of eating disorders such as a binge eating disorder.

  本发明涉及式(I)的新化合物或其药学上可接受的盐，其中R是芳基或杂芳基，可以被一个或多个卤素、C1-C4烷基、C1-C4氧烷基、C1-C4卤代烷基、C1-C4卤代氧烷基、氰基取代；Z1是H、C1-C4烷基或F；Z是CH2、CH(C1-C4烷基)、C(C1-C4烷基)2或键；A是一个6-10成员芳基或杂芳基，可以被一个或多个卤素、C1-C4烷基、C1-C4氧烷基、C1-C4卤代烷基、C1-C4卤代氧烷基、氰基或—C(═O)—X取代；或—O(CH2)0-1R1；B是氢或是一个5-6成员杂芳基、或一个4-6成员杂环、或苯基，可以被一个或多个卤素、C1-C4烷基、C1-C4氧烷基、C1-C4卤代烷基、C1-C4卤代氧烷基、羟基、氰基取代；A和B通过任何原子连接；R1是—(C1-C4)烷基(C1-C4)氧基；或C3-C8环烷基；或R1是一个芳基或杂芳基，可以被一个或多个卤素、C1-C4烷基、C1-C4氧烷基、C1-C4卤代烷基、C1-C4卤代氧烷基、氰基取代；或R1是一个4-6成员杂环，可以被一个或多个卤素、C1-C4烷基、C1-C4氧烷基、C1-C4卤代烷基、C1-C4卤代氧烷基、氰基取代；X是OR2或NR3R4；R2是C1-C4烷基；R3是氢或与R4和氮一起形成一个5-6饱和成员环；R4是C3-C8环烷基；它们的制备方法，用于这些方法的中间体，含有它们的药物组合物以及它们作为NPY Y5受体拮抗剂和用于治疗和/或预防暴饮暴食等进食障碍的药物的用途。
• Host materials for oled
  申请人：Zeng Lichang

  公开号：US20120298966A1

  公开（公告）日：2012-11-29

  Novel aryl silicon and aryl germanium host materials are described. These compounds improve OLED device performance when used as hosts in the emissive layer of the OLED.

  描述了新型芳基硅和芳基锗宿主材料。当这些化合物作为OLED发射层的宿主时，能够提高OLED器件的性能。
• BIPIRIDINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT CONTAINING THE SAME
  申请人：Kimura Masato

  公开号：US20100327265A1

  公开（公告）日：2010-12-30

  The present invention provides a new bipyridine derivative which is suitable for an electron transport material of an organic electronics element and which has bipyridyl central rings as a core, and further provides an organic electroluminescence element containing the derivative. The bipyridine derivative is expressed by the following general formula. (where A 1 , A 2 : represent an aromatic heterocyclic group (except for a carbazolyl group) and an aromatic hydrocarbon group and the aromatic heterocyclic group may be combined; a, b=1 or 2; Ar 1 , Ar 2 : represent a divalent or trivalent aromatic hydrocarbon group which may be substituted by hydrogen atom, an alkyl group, a cycloalkyl group, or an alkoxy group; B 1 , B 2 : represent hydrogen atom, an alkyl group, a cycloalkyl group, an alkoxy group, an aromatic hydrocarbon group, or an aromatic heterocyclic group; and ring E 1 , ring E 2 : represent a pyridine ring, and may have hydrogen atom, an alkyl group, a cycloalkyl group, or an alkoxy group.), which is used as an electron transport material.

  本发明提供了一种新的联吡啶衍生物，适用于有机电子元件的电子传输材料，并且以联吡啶中心环为核心，并进一步提供了含有该衍生物的有机电致发光元件。该联吡啶衍生物由以下通用公式表示（其中A1、A2：表示芳香杂环基团（除了羰基苯胺基团）和芳香烃基团，芳香杂环基团可以结合；a、b=1或2；Ar1、Ar2：表示可以被氢原子、烷基基团、环烷基基团或烷氧基取代的二价或三价芳香烃基团；B1、B2：表示氢原子、烷基基团、环烷基基团、烷氧基、芳香烃基团或芳香杂环基团；环E1、环E2：表示吡啶环，并且可能带有氢原子、烷基基团、环烷基基团或烷氧基），该衍生物用作电子传输材料。
• HEPATITIS C VIRUS INHIBITORS
  申请人：Qiu Yao-Ling

  公开号：US20110300104A1

  公开（公告）日：2011-12-08

  The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit RNA-containing virus, particularly the Hepatitis C Virus (HCV). Consequently, the compounds of the present invention interfere with the life cycle of the Hepatitis C Virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

  本发明公开了具有式（I）的化合物，或其药学上可接受的盐、酯或前药：这些化合物抑制RNA含病毒，特别是丙型肝炎病毒（HCV）。因此，本发明的化合物干扰丙型肝炎病毒的生命周期，并且也可用作抗病毒剂。本发明还涉及包括上述化合物的药物组合物，用于治疗患有HCV感染的受试者。本发明还涉及通过给予包含本发明化合物的药物组合物来治疗受试者的HCV感染的方法。